Nancy Miller-Rich
CIK 1735084 · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$727
Companies
4
Total Filings
24
Lifetime Open-Market Net
$10.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALDX | Director | 413 | $1.76 | $727 | $10.4K | 9 | 2026-06-11 |
| FDMT | Director | — | $8.83 | — | $0 | 5 | 2025-06-20 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Director | 30,415 | $19.00 | $577.9K | $0 | 6 | 2023-05-25 |
| Kadmon Holdings, Inc. (KDMN) Delisted | Director | — | $9.50 | — | $0 | 3 | 2021-11-09 |
Recent Filings · Page 3 of 3
24 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-06-01 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +1,595 | $0 | EDGAR |
| 2020-01-15 | ALDX | Grant (A) | — | $0 | EDGAR |
| 2019-06-21 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +1,570 | $0 | EDGAR |
| 2018-06-22 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +4,373 | $0 | EDGAR |
Showing 21–24 of 24
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.